DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Sanofi Consumer Healthcare India Limited?

Sanofi Consumer Healthcare India Limited has a price-to-earnings (PE) ratio of 34.1 in the Healthcare sector.

What is the market capitalisation of Sanofi Consumer Healthcare India Limited?

Sanofi Consumer Healthcare India Limited has a market capitalisation of approximately ₹8,172 crore.

Is Sanofi Consumer Healthcare India Limited a profitable company?

Sanofi Consumer Healthcare India Limited generates a return on equity of 62.5% with a net profit margin of 27.3%. That is a strong return on shareholder capital.

What is the 52-week high and low of SANOFICONR?

Sanofi Consumer Healthcare India Limited (SANOFICONR) has traded between ₹3,530.1 and ₹5,175.36 over the past 52 weeks, against a current price of ₹3,559.9.

Does Sanofi Consumer Healthcare India Limited pay a dividend?

Yes. Sanofi Consumer Healthcare India Limited currently offers a dividend yield of 1.83%. Dividend payments depend on the board's declaration each year.

Sanofi Consumer Healthcare India Limited

₹3,559.90▼ -13.40 (-0.38%)

SANOFICONR·NSE·Healthcare

Market Cap

8171.61 Cr

PE Ratio

34.14

Volume

1,201

Day High - Low

3611.00 - 3540.10

52W High-Low

5175.36 - 3530.10

₹3,559.90▼ -13.40 (-0.38%)

Market Cap8171.61 Cr

PE Ratio34.14

Volume1,201

Day High - Low3611.00 - 3540.10

52W High-Low5175.36 - 3530.10

Sanofi Consumer Healthcare India Limited (SANOFICONR): company summary

The company's annual revenue and net profit remained flat at ₹878 crore and ₹240 crore respectively.

Sanofi Consumer Healthcare India Limited (SANOFICONR) is a small-cap Healthcare company valued at ₹8,172 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Sanofi Consumer Healthcare India Limited last traded at ₹3,559.9, modestly down 0.38% on the day.
Recent developments: On 2026-09-20, the company reported strong Q1'26 performance with 33% revenue growth, indicating improved business conditions in the quarter.
Financial performance: The company's annual revenue and net profit remained flat at ₹878 crore and ₹240 crore respectively. The latest quarter saw revenue rise 6.7% year-over-year to ₹236 crore, while net profit increased 12.8% to ₹69 crore. The net profit margin stayed unchanged at 27.3%, and return on equity remained strong at 62.5%.
Valuation multiples: The stock trades at 34.1 times earnings, broadly in line with the Healthcare median of 32.0, 27.96 times book value. It yields 1.8%.
Things to watch: The stock is 26.8% below its 52-week high, and promoter holding remained at 71.27% as of 2026-06-30. Foreign institutional holding decreased by 0.16 percentage points in the quarter, while domestic institutional holding increased by 0.29 percentage points.
Where it stands: The company ended the latest quarter with revenue of ₹236 crore and net profit of ₹69 crore, showing growth compared to the same quarter a year earlier. The stock is 26.8% below its 52-week high.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.3/10

Weak

Fair Value

ROE

62.53%

Strong

P/E

34.14x

Fair

Debt / Equity

0.00

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Mixed

Price performance

Day₹3540

₹3611

52W₹3530

₹5175

DocStoX take

Supported by quality (9.2) and risk (8.1), but held back by momentum (0.0). Quality looks strong at 9.2, but that is offset by momentum at 0.0 and valuation at 1.6. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.

DocStoX score

Low confidence

5.3

/10

Weak

Quality

Excellent

ROE 62.5%

Valuation

Expensive

P/E 34.1×

Growth

No data

No multi-year history

Risk

Low risk

D/E 0.00

Momentum

Weak

2% of 52-week range

Scored on 4 of 5 measures — the rest have no data for this company.

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹3,560

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹8,172 Cr

52W High / Low

₹5175 / ₹3530

Dividend Yield

1.83%

Promoter Holding

71.27%

EPS (TTM)

₹104.27

Book Value

₹166.96

Key highlights

Capital works hard — ROCE 84%
Strong returns on equity (63%)
Low leverage — D/E 0.00
Valuation is weak (1.6/10)
Momentum is weak (0.0/10)

4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Sanofi Consumer Healthcare India Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Sanofi Consumer Healthcare India Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Sanofi Consumer Healthcare India Limited with peers

Sanofi Consumer Healthcare India Limited vs Sun Pharmaceutical Industries Limited Sanofi Consumer Healthcare India Limited vs Divi's Laboratories Limited Sanofi Consumer Healthcare India Limited vs Torrent Pharmaceuticals Limited Sanofi Consumer Healthcare India Limited vs Apollo Hospitals Enterprise Limited Sanofi Consumer Healthcare India Limited vs Zydus Lifesciences Limited Sanofi Consumer Healthcare India Limited vs Laurus Labs Limited

Related tools & concepts

Value Sanofi Consumer Healthcare India Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

SANOFICONR newsLatest coverage & filings Open screenerFilter the whole market